What is Germitec?
Germitec operates at the intersection of medical technology and infection control, specializing in automated UV-C High-Level Disinfection (HLD) for ultrasound probes. By replacing traditional chemical-based cleaning methods with its fast, one-button, and environmentally sustainable solutions, the company addresses the critical challenge of cross-contamination in healthcare settings. Its core product portfolio, including the Chronos and Antigermix systems, leverages advanced Yuvee technology to mitigate the risk of Healthcare-Associated Infections (HAIs). This focus on patient safety and operational efficiency has established Germitec as a key player in the global medical equipment market, providing hospitals and clinics with a robust, chemical-free alternative for probe maintenance.
The company's commitment to innovation is reflected in its ability to streamline clinical workflows while maintaining the highest standards of safety. By automating the disinfection process, Germitec not only reduces the burden on medical staff but also ensures consistent, reliable results that are essential for modern diagnostic environments.
How much funding has Germitec raised?
Germitec has raised a total of $30M across 1 funding round:
Other Financing Round
$30M
Other Financing Round (2025): $30M with participation from Eurazeo
Key Investors in Germitec
Eurazeo
A leading global investment firm based in Paris, Eurazeo provides deep sector expertise and long-term support for companies across private equity, venture capital, and private debt, facilitating transformational growth.
What's next for Germitec?
With this major enterprise-level funding, Germitec is poised to scale its manufacturing capabilities and broaden its commercial reach across key global markets. The strategic deployment of this capital will likely focus on enhancing R&D initiatives to further refine its UV-C technology and potentially expand its product line to address broader clinical disinfection needs. As the healthcare industry continues to prioritize infection prevention, Germitec's scalable, eco-friendly approach provides a significant competitive advantage. The company is expected to leverage this financial momentum to strengthen its partnerships with major healthcare providers and diagnostic imaging centers, ultimately driving long-term value and setting new benchmarks for hygiene in the medical imaging space.
See full Germitec company page
